DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Venus Remedies Limited — Board Meeting Intimation

NSE 1 hr ago·14 Oct 2026, 10:44 am

Venus Remedies

Venus Remedies Limited has announced that its Board of Directors will meet on October 26, 2026, to review and approve the company's unaudited financial results for the quarter ended September 2026.

This board meeting is a routine corporate event, but it is significant for investors as it will provide the first glimpse into the company's performance during the third quarter of the fiscal year. The results will reveal how the company is faring against its competitors and whether its recent strategies are yielding the desired growth.

Investors should pay close attention to the company's revenue growth, profit margins, and any commentary from management regarding future outlook. The announcement will be made available on the stock exchanges shortly after the meeting concludes.